Cargando…

Impact of different dose prescription schedules on EQD(2) in high-dose-rate intracavitary brachytherapy of carcinoma cervix

PURPOSE: To observe the effect of different high-dose-rate (HDR) intracavitary brachytherapy dose schedules on equieffective dose in 2 Gy per fraction (EQD(2)). MATERIAL AND METHODS: It is a retrospective study involving 50 cervical cancer patients, who received external radiotherapy of 45 Gy in 25...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Mohan, Thangaraj, Revathy, Alva, Ram Charith, Koushik, Kirthi, Ponni, Arul, Achar, Janaki MG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536140/ https://www.ncbi.nlm.nih.gov/pubmed/31139229 http://dx.doi.org/10.5114/jcb.2019.84586

Ejemplares similares

Equivalent dose in 2 Gy (EQD2) to pelvic lymph nodes using volume based prescription for three brachytherapy applicators — a dosimetric retrospective analysis
por: Revathy, T, et al.
Publicado: (2021)

Interstitial high-dose-rate brachytherapy using cobalt-60 source for cervical cancer: dosimetric and clinical outcomes from a single institute
por: Kumar, Mohan, et al.
Publicado: (2020)

Positional variation of applicators during low dose rate intracavitary brachytherapy for cervical cancer: a prospective study
por: Koushik, Kirthi, et al.
Publicado: (2010)

A study on the variation of bladder and rectal doses with respiration in intracavitary brachytherapy for cervix cancer
por: Prabhakar, Ramachandran, et al.
Publicado: (2010)

Aggressive Approach in a Case of Cancer Cervix with Uremia
por: Janaki, MG, et al.
Publicado: (2010)

Dose comparison between prescription methods according to anatomical variations in intracavitary brachytherapy for cervical cancer
por: Choi, Euncheol, et al.
Publicado: (2018)

The rectum and bladder doses in intracavitary brachytherapy for cervical cancer
por: Sharma, Brahmacharimayum Arunkumar, et al.
Publicado: (2011)

Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy
por: Wang, Binbing, et al.
Publicado: (2021)

Reporting of Inter Fraction Dose Variations of Organs at Risk in Computed Tomography-Guided High Dose Rate Intracavitary Brachytherapy in Carcinoma Cervix
por: Nandi, Moujhuri, et al.
Publicado: (2022)

High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation
por: Stiefel, I., et al.
Publicado: (2021)

Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
por: Sharma, B. Arunkumar, et al.
Publicado: (2011)

Evaluation of Volumetric Doses of Organs at Risk in Carcinoma Cervix Patients with HDR Intracavitary Brachytherapy and Comparison of CT-based and Conventional Plans
por: Srivastava, S., et al.
Publicado: (2019)

A Dosimetric Analysis of the Rectal Doses in Intracavitary Brachytherapy of Carcinoma Cervix: A Prospective Study from a Single Institute
por: Suryadevara, Aparna, et al.
Publicado: (2019)

Clinical implementation of multisequence MRI‐based adaptive intracavitary brachytherapy for cervix cancer
por: Zoberi, Jacqueline E., et al.
Publicado: (2016)

Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
por: Itami, Jun, et al.
Publicado: (2022)

Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in high-dose-rate intracavitary brachytherapy in carcinoma cervix – an institutional study
por: Sharma, Ashutosh Das, et al.
Publicado: (2018)

EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020)

Novel anesthetic technique for combined intracavitary and interstitial brachytherapy for cervix cancer in an outpatient setting
por: Leong, Yiat Horng, et al.
Publicado: (2017)

The effect of central shielding in the dose reporting for cervical cancer in EQD2 era
por: Tharavichitkul, Ekkasit, et al.
Publicado: (2013)

The Relationship Between Late Morbidity and Dose–Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience
por: Zhang, Ning, et al.
Publicado: (2021)

Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer
por: Gupta, Phalguni, et al.
Publicado: (2014)

Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer
por: Chua, Gail Wan Ying, et al.
Publicado: (2017)

A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer
por: Basu, Bishan, et al.
Publicado: (2012)

A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix
por: Bansal, Anil K., et al.
Publicado: (2014)

Inter-institutional comparison of treatment practice for cervical cancer with special emphasis on brachytherapy
por: Ravindran, Ezhilarasi, et al.
Publicado: (2019)

Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma
por: Donnelly, Eric D., et al.
Publicado: (2012)

Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy
por: Siavashpour, Zahra, et al.
Publicado: (2016)

CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer
por: Murakami, Naoya, et al.
Publicado: (2014)

The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix
por: Takahashi, Yutaka, et al.
Publicado: (2012)

Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer
por: Kaliyaperumal, Venkatesan, et al.
Publicado: (2022)

The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer
por: Rockey, William M., et al.
Publicado: (2013)

Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer – a prospective study
por: Sharma, Brahmacharimayum Arunkumar, et al.
Publicado: (2011)

2D to 3D Evaluation of Organs at Risk Doses in Intracavitary Brachytherapy for Cervical Cancer
por: Tan, Yun Inn, et al.
Publicado: (2010)

Comparison of high‐dose‐rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma
por: Sharma, Daya N., et al.
Publicado: (2014)

High-dose-rate intracavitary brachytherapy for recurrent cervical cancer in the vaginal stump after hysterectomy
por: Kozai, Yuka, et al.
Publicado: (2019)

Dosimetric and radiobiological evaluation of treatment plan for cervical cancer high-dose-rate intracavitary brachytherapy
por: Kaur, Gurpreet, et al.
Publicado: (2022)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
por: Viani, Gustavo A, et al.
Publicado: (2009)

A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer
por: Okuma, Kae, et al.
Publicado: (2015)

Dosimetric evaluation of multilumen intracavitary balloon applicator rotation in high‐dose‐rate brachytherapy for breast cancer
por: Kim, Yongbok, et al.
Publicado: (2014)

A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes
por: Siavashpour, Zahra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_24eaf5cuf97s25m4e8m0p43km1